Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-2-15
pubmed:abstractText
Brain natriuretic peptide (BNP) blunts hypoxic pulmonary hypertension in animal models, but its acute hemodynamic effects in patients with pulmonary arterial hypertension (PAH) are not known. The aim of this study was to determine if human B-type natriuretic peptide is a safe and efficacious pulmonary vasodilator in patients with PAH and if the pulmonary hemodynamic effects are potentiated by phosphodiesterase inhibition.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0012-3692
pubmed:author
pubmed:issnType
Print
pubmed:volume
129
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
417-25
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16478861-Administration, Inhalation, pubmed-meshheading:16478861-Administration, Oral, pubmed-meshheading:16478861-Adult, pubmed-meshheading:16478861-Aged, pubmed-meshheading:16478861-Aged, 80 and over, pubmed-meshheading:16478861-Blood Pressure, pubmed-meshheading:16478861-Drug Synergism, pubmed-meshheading:16478861-Drug Therapy, Combination, pubmed-meshheading:16478861-Epoprostenol, pubmed-meshheading:16478861-Female, pubmed-meshheading:16478861-Humans, pubmed-meshheading:16478861-Hypertension, Pulmonary, pubmed-meshheading:16478861-Infusions, Intravenous, pubmed-meshheading:16478861-Male, pubmed-meshheading:16478861-Middle Aged, pubmed-meshheading:16478861-Natriuretic Peptide, Brain, pubmed-meshheading:16478861-Nitric Oxide, pubmed-meshheading:16478861-Phosphodiesterase Inhibitors, pubmed-meshheading:16478861-Piperazines, pubmed-meshheading:16478861-Pulmonary Circulation, pubmed-meshheading:16478861-Purines, pubmed-meshheading:16478861-Sulfones, pubmed-meshheading:16478861-Vascular Resistance, pubmed-meshheading:16478861-Vasodilator Agents
pubmed:year
2006
pubmed:articleTitle
Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
pubmed:affiliation
Division of Pulmonary, Sleep and Critical Care Medicine, Rhode Island Hospital and Brown Medical School, Providence, RI 02903, USA. james_klinger@brown.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't